Another company has taken a write down as a result of holdings in its investment portfolio. This time the company was Bristol-Myers Squibb (BMY). We wrote about the problems with these auction rate securities in a blog post from December:
The Problem with Auction Rate Securities
BMY took a $275 million write down due its poor investment decision.
Monday, February 4, 2008
Auction Rate Securities Bite Again
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment